VBI Vaccines
VBIV
#10526
Rank
S$2.37 M
Marketcap
S$0.08289
Share price
0.00%
Change (1 day)
-89.88%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$12.87. In 2022 the company made an earnings per share (EPS) of S-$16.76 a decrease over its 2021 EPS that were of S-$10.28.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$16.7662.96%
2021S-$10.2828.57%
2020S-$8.00-54.35%
2019S-$17.52-52.58%
2018S-$36.9410.23%
2017S-$33.5114.29%
2016S-$29.32-62.8%
2015S-$78.8390.68%
2014S-$41.34-7.95%
2013S-$44.91-57.97%
2012S-$106.87-78%
2011S-$485.863151.47%
2010S-$14.9423.87%
2009S-$12.06-18.48%
2008S-$14.8012.08%
2007S-$13.20-49.47%
2006S-$26.13
2005N/A-100%
2004S-$11.6211.94%
2003S-$10.38-81.89%
2002S-$57.30196.44%
2001S-$19.3384.33%
2000S-$10.49-65.37%
1999S-$30.28-29.45%
1998S-$42.9229.61%
1997S-$33.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.21-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.66-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.50-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA